Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 257

1.

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.

Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Francis GS, Flohr KH, et al.

N Engl J Med. 1986 Jun 12;314(24):1547-52.

2.

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M, et al.

N Engl J Med. 1991 Aug 1;325(5):303-10.

3.

Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate.

Cohn JN, Archibald DG, Francis GS, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Flohr KH, et al.

Circulation. 1987 May;75(5 Pt 2):IV49-54.

PMID:
3552302
4.
5.
6.
7.

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.

Taylor AL, Ziesche S, Yancy C, Carson P, D'Agostino R Jr, Ferdinand K, Taylor M, Adams K, Sabolinski M, Worcel M, Cohn JN; African-American Heart Failure Trial Investigators.

N Engl J Med. 2004 Nov 11;351(20):2049-57. Epub 2004 Nov 8. Erratum in: N Engl J Med. 2005 Mar 24;352(12):1276.

8.
9.
10.

Effect of vasodilator therapy on mortality in chronic congestive heart failure.

Ghose JC, Chakraborty S, Mondal M, Bhandari B.

J Assoc Physicians India. 1993 May;41(5):269-71.

PMID:
8300456
12.
13.

Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. The V-HeFT II VA Cooperative Studies Group.

Fletcher RD, Cintron GB, Johnson G, Orndorff J, Carson P, Cohn JN.

Circulation. 1993 Jun;87(6 Suppl):VI49-55.

PMID:
8500239
14.
15.

The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group.

Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrell L, Cohn JN.

Circulation. 1993 Jun;87(6 Suppl):VI102-10.

PMID:
8500233
16.

Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.

Ghali JK, Tam SW, Ferdinand KC, Lindenfeld J, Sabolinski ML, Taylor AL, Worcel M, Curry CL, Cohn JN; A-HeFT Investigators.

Am J Cardiovasc Drugs. 2007;7(5):373-80.

PMID:
18041162
18.

Effectiveness of hydralazine/isosorbide dinitrate in racial/ethnic subgroups with heart failure.

Hammermeister KE, Fairclough D, Emsermann CB, Hamman R, Ho M, Phibbs S, Plomondon M, Valuck R, West D, Steiner JF.

Clin Ther. 2009 Mar;31(3):632-43. doi: 10.1016/j.clinthera.2009.03.019.

PMID:
19393854
19.

Results of long-term vasodilator therapy in patients with refractory congestive heart failure.

Walsh WF, Greenberg BH.

Circulation. 1981 Sep;64(3):499-505.

PMID:
7261282

Supplemental Content

Support Center